34(3):562—566.CHALASANI NP.HAYASHI PH.BONKOVSKY HL。et a1.ACGClinical Guideline:The diagnosis and management of idiosyn-cratic drug—induced liver injury[J].Am J Gastroenterol,2014,109(7):950—966,967.Drug—Induced Liver Disease Study Group,Chinese Societyof Hepatology.Chinese Medical Association.Guidelines forthe management of drug—induced liver injury[J].J ClinHepatol,2015.31(”):1752—1769.{in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(”):1752-1769.DONAT M.CONFORTI A。LENTI MC,et a1.Risk of acuteand serious liver injury associated to nimesulide and otherNSAIDs:Data from drug—induced liver injury case—controlstudy in Italy[J]Br J Clin Pharmacol,2016。82(1):238—248.WANG JJ.ZHAO P.Research progress in clinical applicationof S—adenosyl methionine[J/CD].Chin J Liver Dis:Elec—tronic Edition,2011。3(1):57-60.(in Chinese)王建军,赵平.S一腺苷蛋氨酸临床应用研究进展[J/CD].中国肝脏病杂志:电子版,2011。3(1):57—60.LI XY.Effectiveness and safety of adenosine methionine intreatment of cholestatic hepatitis[J]Clin Res Pract,20